Efficient regulation of zinc homeostasis makes the diagnosis of zinc deficiency and excess difficult, and no single measurement is sufficiently specific or sensitive on its own for this purpose. Dietary zinc content and availability, the prevalence of stunting, and average plasma zinc concentrations in a population could give an estimate of the risk of zinc deficiency. In individuals, plasma zinc concentration, urinary zinc excretion, and the response to an increased zinc intake can provide information about the metabolic state with regard to zinc. Zinc has a low toxicity, but an excessive intake could interfere with copper metabolism.
Introduction
Several characteristics of zinc metabolism have to be kept in mind when the risk or presence of deficiency or excess of zinc is to be assessed in individuals and populations. There is no storage of zinc in the conventional sense. The majority (80%-90%) of zinc in the body is found in muscle and bone. However, the concentration of zinc in muscle and most other cells is kept constant over long periods of low intake and is not substantially decreased, even in conditions of clinical zinc deficiency. In conditions of catabolism, zinc is released from muscle and may be available for biological functions. In a similar way, bone resorption will lead to release of zinc, but there is no known mechanism for mobilizing zinc from bone or tissues to cover an increased requirement of zinc. The constant tissue and body zinc content is achieved by changes in absorptive efficiency and endogenous excretion of zinc. The changes in intestinal endogenous excretion are quantitatively the most important, and apparent zinc balance can thus be maintained over a wide range of intakes.
The clinical features of severe zinc deficiency are growth retardation, delayed sexual and bone maturation, dermatitis, loss of hair, diarrhea, defects in the immune system, impairment of taste acuity, and behavioral changes [1] . Supplying zinc rapidly reverses the external signs of deficiency and improves the other characteristics. However, none of these signs of zinc deficiency is sufficiently specific or sensitive on its own to detect marginal or subclinical zinc deficiency. In analogy with approaches made for other nutrients, attempts have been made to evaluate zinc status from measurements of zinc concentration in different tissues, the activity of zinc-dependent enzymes, body pool sizes, and selected functional indices. Each of these measurements has advantages and limitations, and their usefulness depends on the context in which they are to be applied. Some relevant aspects of these indices are summarized below. Information about these measurements can be found elsewhere [2, 3] . Their usefulness is also evaluated from results of experimental zinc deprivation in humans and response to supplementation in population studies.
Putative indices of zinc status

Compositional analyses
Serum or plasma zinc
The most commonly used measurement of zinc status is plasma or serum zinc, despite the fact that less than 0.1% of body zinc is present in plasma and the concentration appears to be under strict homeostatic control. Zinc can be temporarily redistributed from plasma to other tissue or the concentrations can be changed by conditions unrelated to zinc status. Infections, fever, food intake, and pregnancy lower plasma zinc, whereas starvation and catabolism increase it.
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Plasma zinc is also depressed at times of rapid tissue growth [4] . Despite these limitations, the fact that plasma zinc concentrations are normally distributed in healthy populations makes it possible to establish reference values to be used to identify individuals at risk for a low zinc status. An average population plasma zinc concentration lower than that of a well-nourished population should consequently be regarded as an indication of a greater risk of zinc deficiency. In zinc supplementation studies in children, initial average plasma zinc concentrations less than 12.2 µmol/L appeared to be associated with a higher body response in weight gain [5] .
When collecting plasma samples for zinc analysis, precautions have to be taken to avoid hemolysis and contamination of samples and reagents with rubber and other potential sources of zinc. Reference serum samples are available and should be used for quality control. A fasting plasma zinc concentration of 9 mmol/L or a postprandial concentration of 8.4 mmol/L has been suggested as a cutoff levels for low plasma zinc concentration.
Erythrocyte zinc
The concentration of zinc in erythrocytes is approximately 10 times higher than that in plasma. The slow turnover rate of erythrocytes means that their content of zinc cannot reflect recent changes in zinc supply, but they may be useful for studies of chronic zinc deprivation. Experimental zinc depletion studies lasting up to 10 to 12 weeks have, however, not shown consistent changes in erythrocyte zinc. Cutoff levels have not been established, and at present erythrocyte zinc is not a useful measure of zinc status.
Leukocyte zinc
Because of their shorter half-life, leukocytes are assumed to be more sensitive to changes in zinc supply than erythrocytes. However, the different subsets of white cells have different half-lives and also different zinc contents. Thus, analyses of zinc content of mixed leukocytes may be difficult to interpret. The differential separation of leukocyte subsets is also technically difficult.
Hair zinc
Integumental and hair zinc concentrations respond to changes in zinc supply, and monitoring of hair zinc content appears to be a useful marker for the response to an increased zinc supply [6] . However, with severe zinc deprivation, increased hair zinc levels have been observed in animals and malnourished children [7] , probably because of a reduced rate of hair growth. The sampling technique (e.g., the distance from the scalp) and the cleaning of the samples, with removal of external contamination without extracting intrinsic zinc, are also crucial for interpretation of the zinc content of hair [8] . A cutoff level of 1.07 µmol/g has been suggested as an indication of low zinc status.
Urinary zinc excretion
At adequate zinc intakes, 24-hour urinary zinc excretion is relatively constant (approximately 4 to 9 mmol per 24 hours) and does not reflect day-to-day variations in zinc intake. At chronically low zinc intakes, urinary zinc excretion is reduced, apparently as part of the homeostatic regulation of body zinc content. Muscle catabolism increases urinary zinc excretion, and anabolism may depress it. Drugs with chelating abilities can increase urinary zinc excretion, as can alcoholism and liver disease. Thus, the pathological and metabolic state of the individual should be considered when evaluating urinary zinc excretion, and this measure does not stand alone as a useful indicator of zinc deprivation in an individual. Similar to hair zinc, determination of baseline and postintervention urinary zinc excretion and comparison with normal values may be useful for evaluating the efficiency of zinc intervention programs.
Rapidly exchangeable zinc pools
The rapid onset and disappearance of clinical zincdeficiency symptoms suggest the presence of an easily accessible pool of zinc. Isotope studies evaluating turnover rate in plasma or urinary samples have revealed a relactively small, rapidly exchangeable pool of zinc on the order of 100 to 200 mg (approximately 10%-20% of total body zinc) [9] [10] [11] [12] . The technique requires advanced analytical equipment and technical expertise, which, together with the high cost of stable isotopes, limits its usefulness for population studies. With further evaluation of this technique in chronic or acute zinc depletion and repletion, it may be used as a gold standard for establishing functional cutoff levels for more easily measured indices, e.g., plasma zinc.
Functional indices
In theory, the activities of zinc-dependent enzymes in plasma or blood cells should be useful as functional indices of zinc status. A number of enzymes have been studied in this respect, e.g., alkaline phosphatase, carboxypeptidase, lactate dehydrogenase, 5′-nucleotidase, thymidine kinase, D -amino-laevulinic acid dehydratase, and angiotensin-1-converting enzyme. However, so far none of them has proven to be a reliable indicator of zinc deprivation.
On the basis of observations in severe zinc deficiency, other functional tests have been suggested as indices of zinc status, e.g., taste acuity, dark adaptation ability (electroretinography), cutaneous hypersensitivity, and leukocyte chemotaxis. Although these tests have not been found to be specific enough to diagnose zinc deficiency in a population or an individual, they can be useful in monitoring the response to zinc supplementation or other improvements of zinc supply.
Experimental zinc deprivation and indices of zinc status
A limited number of experimental zinc-deprivation studies have been conducted in healthy, presumably well-nourished adult subjects over periods ranging from four to nine weeks up to six months. In extreme zinc-depletion studies using semipurified formula diets and intakes close to zero for five to nine weeks [13] [14] [15] , marked reductions in plasma zinc and urinary and fecal zinc excretion were observed in all subjects. The decline in urinary zinc paralleled the changes in plasma zinc for an individual, but the relation differed among subjects. Some individuals showed minor clinical signs, such as dermatitis and sore throat, which could be attributed to zinc deficiency, whereas more obvious zinc deficiency signs (acneiform skin lesions) were observed in only one case [15] . The rapid response to these low zinc intakes suggests that accessible zinc stores are relatively small.
The responses to acute and complete withdrawal of zinc supply, however, may not fully reflect the response to more realistic dietary zinc deprivations. When the zinc intake of presumably well-nourished adults was reduced from 250 µmol/day (a typical zinc intake in American adults) to 84 µmol/day (around the minimum intake in most dietary intake studies), no changes in urinary or plasma zinc were observed, and the body zinc content seemed to be maintained mainly by decreased endogenous fecal zinc excretion [16] . Also, with lower zinc intakes (40-50 µmol/day), circulating zinc concentrations and activities of zinccontaining enzymes can be maintained within normal range over several months [17, 18] . Johnson et al. [19] studied the effect of five levels of zinc intake, from 159 to 22 µmol/day in 35-day periods. Only at the lowest intake was plasma zinc reduced from 12.7 ± 1.2 to 11.2 ± 2.8 mmol/L. The probable explanation for the modest response to low zinc intake is a high bioavailability of zinc from the semisynthetic diets, allowing for maximal adaptation in absorption and endogenous excretion.
These adaptive mechanisms may not be as efficient when diets with a low availability of zinc are consumed. Dietary manipulation to achieve a low zinc content and a low bioavailability has been used in experimental studies to induce mild zinc deficiency in adults. Rabbani et al. [20] used an EDTA-washed soy-based diet, and Ruz et al. [21] used a diet with soy protein and albumin with added sodium phytate. In 15 male subjects (mean age, 25 years), intake of a diet low in zinc (61 µmol/day) and high in phytate (1.32 g/day; phytate:zinc molar ratio, 58) for six weeks resulted in a decline in plasma zinc from 14.8 ± 1.7 to 12.2 ± 2.0 µmol/L and a decline in urinary zinc from 8.0 ± 2.7 to 4.3 ± 2.3 µmol/L [21] . Changes in taste acuity and cellular immune response were also observed, whereas cellular zinc concentrations were not affected. In another study [22] , a significant decline in alkaline phosphatase activity in erythrocyte membranes was observed. In eight young adult men of the same age as those in the study by Ruz et al. [21] , intake of 63.1 µmol zinc/day for six months reduced plasma zinc from 17.6 ± 0.5 to 16.1 ± 1.8 µmol/L [23] . Mean urinary zinc output was reduced from 11.1 ± 2.8 to 7.7 ± 2.0 µmol/24 h. Cellular zinc levels declined significantly only after 20 weeks, whereas a reduction in lymphocyte ecto-5′-nucleotidase activity was observed after four to eight weeks of zinc restriction [24] . The endogenous fecal zinc excretion was reduced from 65.2 µmol/day at baseline to 47.7 µmol/day after two months and 27.1 µmol/day at the end of the six months of depletion. Zinc absorption was significantly increased at two and four months of zinc restriction but was not significantly different from baseline at the end of the depletion period. This suggests that the endogenous fecal excretion is crucial for zinc homeostasis. Any impairment of this function, e.g., by chronic or acute intestinal infection and diarrhea, would increase the risk of zinc deficiency at marginal to low intakes of zinc.
The results from the experimental zinc-depletion studies suggest that a reduction in urinary zinc excretion is an early marker for a low body zinc supply. Urinary zinc excretion drops before any detectable changes in serum or plasma zinc. The changes in plasma and urinary zinc observed in the different experimental studies are, however, not consistent, and the values are often within normal ranges, even after long-term marginal zinc intakes. Most of the other suggested indices of zinc status are not affected, even in studies with zinc intakes lower than the minimum intakes of most populations.
Assessment of zinc status in individuals and populations
The approaches taken for assessment of zinc status depend on the purpose of the assessment. Different techniques might be applied, depending on whether the purpose is to assess the risk of deficiency, the actual prevalence of deficiency, or the response to an intervention program aimed at improving the zinc supply. An evaluation of the dietary zinc supply, not only in regard to total zinc intake but also with an estimate of the amount of absorbable zinc, will give an initial indication of the risk of zinc deficiency in a population. According to available data for zinc requirement and food intake in different countries, 68% to 94% of children in a number of developing countries were considered at risk for zinc deficiency, as compared with only 1% of Canadian children [25] . For assessing the prevalence of zinc deficiency in a population, a careful evaluation of plasma zinc concentrations in representative samples of the population and of the prevalence of stunting seems to be useful. The prevalence of conditions that increase the requirement of zinc, e.g., diarrhea, infections, and malnutrition, also needs to be considered. Additional information can be obtained from measurements of hair zinc concentration and urinary zinc excretion.
To monitor the response to zinc intervention in a population, representative sampling of plasma zinc is still the best available marker of zinc status. Whenever possible, functional indices, such as immune response and dark adaptation ability, should be included.
In individuals, a serum or plasma zinc value below reference values for the population, in the absence of acute infections, and a low urinary zinc excretion suggest a marginal zinc status. Enzyme assays or molecular tools may be used in the future as they become available. Zinc has a central role in regulation of gene expression, especially through the metal response elements of metallothionein genes, and it was recently demonstrated that metallothionein mRNA in lymphocytes responded to a change in zinc intake from 210 to 70 µmol/day, while plasma zinc was unaffected [26] .
Zinc toxicity and assessment of excess zinc
Zinc has a low toxicity. Acute toxicity symptoms, such as nausea, vomiting, diarrhea, fever, and lethargy, are observed only after ingestion of gram doses. When zinc intake is increased, homeostasis is maintained through increased urinary and endogenous fecal excretion. Long-term zinc intakes higher than requirement could, however, interact with the metabolism of other trace elements. Interactions with copper are well described. At an intake of 50 mg/day, changes in CuZn-superoxide dismutase in erythrocytes have been reported [27, 28] . At higher doses of zinc (450-660 mg/day), impairments of indices of copper status and anemia and changes in serum lipid patterns and immune response have been observed [29] [30] [31] [32] . Nutritional rehabilitation of marasmic children with a zinc-fortified milk appears to impair monocyte function [33] . Dose-response studies of the effect of increased zinc intake on copper status and immune response are lacking. The above-cited studies suggest, however, that care should be taken not to impair copper status during zinc intervention studies.
Research needs
Despite the limitations of serum zinc as an indicator of zinc status, it remains the only option in many situations. The relation between serum zinc concentration, the rapidly exchangeable zinc pool size, and functional or other signs of zinc deficiency needs to be established. If a critical zinc pool size associated with impairment of zinc-dependent functions can be identified, it may also be possible to establish functional cutoff levels of serum zinc for individuals and for average population values associated with an increased risk of deficiency. Identification of early markers of adaptive changes in zinc metabolism would also be useful to identify individuals or population groups at increased risk of zinc deficiency. Before large population interventions are undertaken to improve the availability and consumption of zinc in populations, the lowest dose of zinc with no measurable negative effects on copper or immune status needs to be established.
